You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 94 23 486 or email: subscribe@krixos.com |
|
Most viewed
- 1. Adcendo ApS Announces Clinical Collaboration and Supply Agreement with MSD to Evaluate ADCE-T02 in Combination with KEYTRUDA® (Pembrolizumab) in a Phase Ib Study in Patients with Advanced Solid Tumors
- 2. Anlotinib Plus Immune Checkpoint Inhibitors versus Chemotherapy in Elderly Patients with Extensive-Stage Small-Cell Lung Cancer: A Real World, Exploratory Study
- 3. Junshi Biosciences Announces Primary Endpoints Met in Final Analysis of Phase 3 Study for Perioperative Toripalimab plus Chemotherapy for Resectable Stage II-III NSCLC
- 4. Scientists are raising new questions about vitamin B12 and cancer
- 5. Blockbuster sales, lawsuits, and approvals: is there a recovery in sight for Bayer in 2026?
- 6. Sacituzumab govitecan receives positive CHMP opinion in first-line metastatic triple-negative Breast cancer
- 7. Cholesterol-craving cancers need lipid enzymes to use metabolites for growth
- 8. Government of Nepal Grants Key Environmental Approval for $30 Million Binaytara Cancer Hospital, Madhesh Province's First Comprehensive Cancer Center
Last updated at 19:51 GMT
